Table 4.
Recurrences
| SLN cohort N=642 |
LND cohort N=493 |
P | |
|---|---|---|---|
|
Disease progression/recurrence within 3 years, N (%) |
19 (3.0) | 14 (2.8) | 0.35 |
| 3-year disease-free survival, % (95% CI) | 94.9 (92.4–97.5) | 96.8 (95.2–98.5) | |
| Route of first recurrence, N | |||
| Hematogenous only | 4 | - | |
| Hematogenous and lymphatic | - | 1 | |
| Hematogenous and peritoneal | 1 | 1 | |
| Hematogenous, lymphatic and peritoneal | 1 | 1 | |
| Lymphatic only | 2 | 2 | |
| Lymphatic and peritoneal | 1 | - | |
| Vaginal only | 9 | 4 | |
| Vaginal and peritoneal | - | 1 | |
| Peritoneal only | 1 | 4 |
SLN, sentinel lymph node; LND, lymph node dissection